OptimizeRx (OPRX) Other Non-Current Assets (2010 - 2026)

OptimizeRx has reported Other Non-Current Assets for 17 years, with the latest figure at $111.0 million in Q1 2026.

• Quarterly Other Non-Current Assets fell 4.24% year-over-year to $111.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $111.0 million (down 4.24% YoY) and the FY2025 annual result came in at $112.1 million, down 4.23% from the prior year.
• Other Non-Current Assets declined to $111.0 million in Q1 2026 per OPRX's latest filing, from $112.1 million in the prior quarter.
• Over five years, Other Non-Current Assets peaked at $128.9 million in Q4 2023 and troughed at $5051.0 in Q4 2022.
• A 5-year average of $68.1 million and a median of $36.9 million in 2022 frame the typical range for Other Non-Current Assets.
• The sharpest annual moves came in 2022 and 2023: Other Non-Current Assets sank 99.98% in 2022, then soared 2551751.12% in 2023.
• Over 5 years, Other Non-Current Assets stood at $5051.0 in 2022, then jumped by 2551751.12% to $128.9 million in 2023, then declined by 9.19% to $117.0 million in 2024, then retreated by 4.23% to $112.1 million in 2025, then decreased by 0.99% to $111.0 million in 2026.
• According to Business Quant data, Other Non-Current Assets over the past three periods registered $111.0 million, $112.1 million, and $113.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.